A systems approach to cancer therapy (antiangiogenics plus standard cytotoxics->mechanism(s) of interaction)

被引：106

作者：

Teicher, BA ^{[1
]}

机构：

[1] JOINT CTR RADIAT THERAPY, BOSTON, MA 02115 USA

来源：

CANCER AND METASTASIS REVIEWS | 1996年 / 15卷 / 02期

关键词：

antiangiogenic agents; combined modality therapy; TNP-470; minocycline; Lewis lung carcinoma;

D O I：

10.1007/BF00437479

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：247 / 272

页数：26

共 315 条

[51]

DAVIES B, 1993, CANCER RES, V53, P2087

[52] PURIFICATION AND CHARACTERIZATION OF A COLLAGENASE INHIBITOR PRODUCED BY BOVINE VASCULAR SMOOTH-MUSCLE CELLS [J].

DECLERCK, YA .

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1988, 265 (01) :28-37

[53] ANGIOGENESIS, NEOVASCULAR PROLIFERATION AND VASCULAR PATHOPHYSIOLOGY AS TARGETS FOR CANCER-THERAPY [J].

DENEKAMP, J .

BRITISH JOURNAL OF RADIOLOGY, 1993, 66 (783) :181-196

[54] TRANSFORMING GROWTH FACTOR-ALPHA [J].

DERYNCK, R .

MOLECULAR REPRODUCTION AND DEVELOPMENT, 1990, 27 (01) :3-9

[55] MORPHOLOGIC AND HEMODYNAMIC COMPARISON OF TUMOR AND HEALING NORMAL TISSUE MICROVASCULATURE [J].

DEWHIRST, MW ;

TSO, CY ;

OLIVER, R ;

GUSTAFSON, CS ;

SECOMB, TW ;

GROSS, JF .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1989, 17 (01) :91-99

[56] 1-BUTYRYL-GLYCEROL - A NOVEL ANGIOGENESIS FACTOR SECRETED BY DIFFERENTIATING ADIPOCYTES [J].

DOBSON, DE ;

KAMBE, A ;

BLOCK, E ;

DION, T ;

LU, H ;

CASTELLOT, JJ ;

SPIEGELMAN, BM .

CELL, 1990, 61 (02) :223-230

[57]

Dorudi Sina, 1993, Current Opinion in Oncology, V5, P130

[58] STIMULATION OF ANGIOGENESIS BY ADENOSINE ON THE CHICK CHORIOALLANTOIC MEMBRANE [J].

DUSSEAU, JW ;

HUTCHINS, PM ;

MALBASA, DS .

CIRCULATION RESEARCH, 1986, 59 (02) :163-170

[59]

DVORAK HF, 1986, NEW ENGL J MED, V315, P1650

[60]

EISENBACH L, 1985, JNCI-J NATL CANCER I, V74, P87

← 1 2 3 4 5 6 7 8 9 10 →